Related Experiment Videos
Proteolytic antibody light chains alter beta-amyloid aggregation and prevent cytotoxicity
Ruitian Liu1, Chad McAllister, Yuri Lyubchenko
1Department of Chemical and Materials Engineering, Arizona State University, Tempe, Arizona 85287, USA.
Biochemistry
|August 4, 2004
Summary
Antibody fragments targeting beta-amyloid (Abeta) show therapeutic potential for Alzheimer's disease (AD). One fragment neutralizes Abeta toxicity, while another increases aggregation, highlighting the need for caution with alpha-secretase strategies.
Area of Science:
- Neuroscience
- Biochemistry
- Immunology
Background:
- Beta-amyloid (Abeta) peptide is a key component of neuritic plaques in Alzheimer's disease (AD).
- Alpha-secretase activity, which cleaves Abeta, is a proposed therapeutic target for AD.
- Antibody fragments with proteolytic activity against Abeta have been previously identified.
Purpose of the Study:
- To investigate the effects of two antibody fragments with different proteolytic activities on Abeta aggregation and cytotoxicity.
- To evaluate the therapeutic potential of antibody-mediated Abeta degradation for Alzheimer's disease.
Main Methods:
- Cleavage of Abeta40 using two distinct antibody light-chain fragments: hk14 (carboxypeptidase-like) and c23.5 (alpha-secretase-like).
- Analysis of Abeta aggregation rates and cytotoxicity following enzymatic cleavage.
- Characterization of the solubility of cleaved Abeta fragments.
Main Results:
- The hk14 fragment altered Abeta aggregation and neutralized its cytotoxic effects.
- The c23.5 fragment significantly increased Abeta aggregation rate without a corresponding increase in cytotoxicity.
- Increased aggregation by c23.5 was linked to decreased solubility of Abeta fragments, particularly Abeta17-40.
Conclusions:
- Antibody fragment-mediated proteolytic degradation of Abeta offers a potential therapeutic strategy for controlling Abeta aggregation and toxicity in AD.
- Enhancing alpha-secretase activity as a therapeutic approach requires careful consideration due to its potential to significantly increase Abeta aggregation.